Litecoin Treasury Firm MEI Pharma Rebrands as Lite Strategy; Ticker Changes to LITS as Charlie Lee Joins Board

COINOTAG News reported on September 10 that US-listed biopharma company MEI Pharma has completed a corporate rebrand to Lite Strategy, with its exchange ticker changing from MEIP to LITS. The transition on the US stock market is scheduled to take effect at market open on September 11, 2025, reflecting a formal change to the company’s public identity and investor communications.

The company also confirmed that Litecoin founder Charlie Lee has joined the firm’s board of directors, bringing sector-specific experience to corporate governance and strategic oversight. These corporate actions were presented in official filings and press releases, providing verifiable updates for shareholders and market participants.